Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial

Background: Presumed benign ovarian tumours (PBOT) are defined by the International Ovarian Tumour Analysis (IOTA) group, without suspected sonographic criteria of cancer, without ascites or metastasis. The aim is to evaluate the efficacy of human epididymis protein 4 (HE4), cancer antigen 125 (CA12...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Clin Med
मुख्य लेखकों: Dochez, Vincent, Randet, Mélanie, Renaudeau, Céline, Dimet, Jérôme, Le Thuaut, Aurélie, Winer, Norbert, Thubert, Thibault, Vaucel, Edouard, Caillon, Hélène, Ducarme, Guillaume
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI 2019
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6912210/
https://ncbi.nlm.nih.gov/pubmed/31699959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8111784
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन